Authors: Gardani, G Meregalli, S

Citation: G. Gardani et S. Meregalli, University hospital: Problem or solution?, TUMORI, 87(4), 2001, pp. S60-S60

Authors: Bertoni, F de Tomasi, D Vitali, E De Agostini, A Baroncelli, G Cafaro, I D'Affronto, C Richetti, A Valli, M Palazzi, M Meregalli, S Asnaghi, D Arienti, V Cavallini, D Pradella, R Di Lorenzo, I

Citation: F. Bertoni et al., Radiotherapy for early breast cancer in elderly women: A subgroup analysisfrom a multicenter, observational, prospective study on 1610 patients, TUMORI, 87(4), 2001, pp. S139-S139

Authors: Capovilla, G Rubboli, G Beccaria, F Meregalli, S Veggiotti, P Giambelli, PM Meletti, S Tassinari, CA

Citation: G. Capovilla et al., Intermittent falls and fecal incontinence as a manifestation of epileptic negative myoclonus in idiopathic partial epilepsy of childhood, NEUROPEDIAT, 31(5), 2000, pp. 273-275

Authors: Bordin, V Giani, L Meregalli, S Bukovec, R Vaghi, MM Mandala, M Paolorossi, F Ardizzoia, A Tancini, G Barni, S Frigerio, F Fumagalli, L Bordoni, A Valusani, G Di Felice, G Lissoni, P

Citation: V. Bordin et al., Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients, UROL INTERN, 64(1), 2000, pp. 3-8

Authors: Lissoni, P Vigore, L Ferranti, R Bukovec, R Meregalli, S Mandala, M Barni, S Tancini, G Fumagalli, L Giani, L

Citation: P. Lissoni et al., Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease, J BIOL REG, 13(4), 1999, pp. 216-219

Authors: Fumagalli, L Lissoni, P Di Felice, G Meregalli, S Valsuani, G Mengo, S Rovelli, F

Citation: L. Fumagalli et al., Pretreatment serum markers and lymphocyte response to interleukin-2 therapy, BR J CANC, 80(3-4), 1999, pp. 407-411